Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
623
datasets available to search
ShareScore release 0.9.0
Dataset results
623 results for “hormonal therapy”
Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
ClinicalTrials.gov study NCT03969121. IPD Sharing: UNDECIDED. Countries: 5. Publications: 1.
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov study NCT00005810. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy
ClinicalTrials.gov study NCT03458559. IPD Sharing: NO. Countries: 1. Publications: 3.
Effectiveness of Intrauterine Growth Hormone Administration as an add-on Therapy to Conventional Hormone Therapy Compared to Placebo in Patients With Thin Endometrium Undergoing Frozen Thawed Embryo T
ClinicalTrials.gov study NCT06379659. IPD Sharing: NO. Countries: 1. Publications: 5.
Data from: Systemic thyroid hormone status during levothyroxine therapy in hypothyroidism: a systematic review and meta-analysis
Open the record for dataset details and reuse information.
Data from: Association of perceived tinnitus with duration of hormone replacement therapy in Korean postmenopausal women: a cross-sectional study
Objective: The purpose of this study was to determine the relationship between hormone replacement therapy and tinnitus in South Korea using data from the Korea National Health and Nutrition Examination Surveys (KNHANES) (2010 ~ 2012). Study Design : Cross-sectional analysis of a nationwide health survey. Methods: KNHANES is a nationally representative cross-sectional survey of South Korea population. Only postmenopausal women aged 19-65 years were included in the study (n = 2736). Auditory function was evaluated using pure-tone audiometric testing according to established KNHANES protocols. Subjects were questioned about their experience with tinnitus. Exogenous hormone-related factors included the starting age and duration of hormone replacement therapy Results: The overall prevalence of tinnitus was 22.2% among postmenopausal women. 1) Tinnitus severity was significantly higher in women using hormone replacement therapy (p = 0.0024) and 2) significantly lower in women who breast-fed their children (p = 0.0386). 3) According to logistic regression models, the longer duration of hormone replacement therapy was significantly associated with increasing tinnitus (OR = 1.323, 95% CI = 1.007-1.737, p = 0.0441). Conclusion: A longer duration of hormone replacement therapy was associated with developing tinnitus in Korean postmenopausal women. Further experimental and epidemiological researches are needed to elucidate the causal relationship between hormone replacement therapy and tinnitus.
ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
ClinicalTrials.gov study NCT00471718. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer
ClinicalTrials.gov study NCT02560051. IPD Sharing: NO. Countries: 1. Publications: 0.
Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov study NCT00544830. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
ClinicalTrials.gov study NCT04076059. IPD Sharing: YES. Countries: 1. Publications: 0.
Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors
ClinicalTrials.gov study NCT01831076. IPD Sharing: NO. Countries: 1. Publications: 0.
Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer
ClinicalTrials.gov study NCT02291913. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hormone Replacement Therapy and Prothrombotic Variants
ClinicalTrials.gov study NCT00049933. IPD Sharing: Not stated. Countries: 0. Publications: 5.
Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy
ClinicalTrials.gov study NCT01422408. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
ClinicalTrials.gov study NCT01720602. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes
ClinicalTrials.gov study NCT06715514. IPD Sharing: YES. Countries: 1. Publications: 0.
S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
ClinicalTrials.gov study NCT01309672. IPD Sharing: YES. Countries: 1. Publications: 0.
Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer
ClinicalTrials.gov study NCT01819285. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT02668666. IPD Sharing: NO. Countries: 1. Publications: 0.
Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov study NCT00049257. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.